| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9898 |
| Human Intestinal Absorption | HIA+ | 0.8728 |
| Caco-2 Permeability | Caco2- | 0.5332 |
| P-glycoprotein Substrate | Non-substrate | 0.8690 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7993 |
| Non-inhibitor | 0.9721 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9138 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6596 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7494 |
| CYP450 2D6 Substrate | Non-substrate | 0.8281 |
| CYP450 3A4 Substrate | Substrate | 0.5208 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8031 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7654 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9215 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7004 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6190 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9066 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9888 |
| Non-inhibitor | 0.9415 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Carcinogens | 0.5421 |
| Fish Toxicity | Low FHMT | 0.6985 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5146 |
| Honey Bee Toxicity | High HBT | 0.8764 |
| Biodegradation | Not ready biodegradable | 0.7651 |
| Acute Oral Toxicity | II | 0.7694 |
| Carcinogenicity (Three-class) | Non-required | 0.7024 |